Cargando…

Tetra­aqua­bis­(N,N-dimethyl­formamide-κO)zinc(II) bis­[(2-{3-[2-(carboxyl­ato­meth­oxy-κ(2) O,O′)phen­yl]pyrazol-1-yl-κN (2)}acetato-κO)chloridozincate(II)]

The asymmetric unit of the title compound, [Zn(C(3)H(7)NO)(2)(H(2)O)(4)][Zn(C(13)H(10)N(2)O(5))Cl](2), is composed of a single anion and half a cation. The Zn(II) atom in the monoanion has a distorted triganol–pyramidal geometry, being coordinated by three O atoms and one N atom from one 2-{3-[2-(ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jie, Shen, Lei, Ji, Cheng, Shen, Xiao-Feng, Yang, Gao-Weng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379139/
https://www.ncbi.nlm.nih.gov/pubmed/22719360
http://dx.doi.org/10.1107/S1600536812023045
_version_ 1782236134968918016
author Yang, Jie
Shen, Lei
Ji, Cheng
Shen, Xiao-Feng
Yang, Gao-Weng
author_facet Yang, Jie
Shen, Lei
Ji, Cheng
Shen, Xiao-Feng
Yang, Gao-Weng
author_sort Yang, Jie
collection PubMed
description The asymmetric unit of the title compound, [Zn(C(3)H(7)NO)(2)(H(2)O)(4)][Zn(C(13)H(10)N(2)O(5))Cl](2), is composed of a single anion and half a cation. The Zn(II) atom in the monoanion has a distorted triganol–pyramidal geometry, being coordinated by three O atoms and one N atom from one 2-{3-[2-(carboxyl­ato­meth­oxy)phen­yl]pyrazol-1-yl}acetate ligand and one Cl atom. In the dication, the Zn(II) atom is located on an inversion center and is coordinated by six O atoms in a slightly distorted octa­hedral geometry. In the crystal, the ions are linked by O—H⋯O hydrogen bonds, forming a two-dimensional network lying parallel to the ab plane. There are also C—H⋯O and C—H⋯Cl inter­actions present, which lead to the formation of a three-dimensional structure.
format Online
Article
Text
id pubmed-3379139
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-33791392012-06-20 Tetra­aqua­bis­(N,N-dimethyl­formamide-κO)zinc(II) bis­[(2-{3-[2-(carboxyl­ato­meth­oxy-κ(2) O,O′)phen­yl]pyrazol-1-yl-κN (2)}acetato-κO)chloridozincate(II)] Yang, Jie Shen, Lei Ji, Cheng Shen, Xiao-Feng Yang, Gao-Weng Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers The asymmetric unit of the title compound, [Zn(C(3)H(7)NO)(2)(H(2)O)(4)][Zn(C(13)H(10)N(2)O(5))Cl](2), is composed of a single anion and half a cation. The Zn(II) atom in the monoanion has a distorted triganol–pyramidal geometry, being coordinated by three O atoms and one N atom from one 2-{3-[2-(carboxyl­ato­meth­oxy)phen­yl]pyrazol-1-yl}acetate ligand and one Cl atom. In the dication, the Zn(II) atom is located on an inversion center and is coordinated by six O atoms in a slightly distorted octa­hedral geometry. In the crystal, the ions are linked by O—H⋯O hydrogen bonds, forming a two-dimensional network lying parallel to the ab plane. There are also C—H⋯O and C—H⋯Cl inter­actions present, which lead to the formation of a three-dimensional structure. International Union of Crystallography 2012-05-26 /pmc/articles/PMC3379139/ /pubmed/22719360 http://dx.doi.org/10.1107/S1600536812023045 Text en © Yang et al. 2012 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Yang, Jie
Shen, Lei
Ji, Cheng
Shen, Xiao-Feng
Yang, Gao-Weng
Tetra­aqua­bis­(N,N-dimethyl­formamide-κO)zinc(II) bis­[(2-{3-[2-(carboxyl­ato­meth­oxy-κ(2) O,O′)phen­yl]pyrazol-1-yl-κN (2)}acetato-κO)chloridozincate(II)]
title Tetra­aqua­bis­(N,N-dimethyl­formamide-κO)zinc(II) bis­[(2-{3-[2-(carboxyl­ato­meth­oxy-κ(2) O,O′)phen­yl]pyrazol-1-yl-κN (2)}acetato-κO)chloridozincate(II)]
title_full Tetra­aqua­bis­(N,N-dimethyl­formamide-κO)zinc(II) bis­[(2-{3-[2-(carboxyl­ato­meth­oxy-κ(2) O,O′)phen­yl]pyrazol-1-yl-κN (2)}acetato-κO)chloridozincate(II)]
title_fullStr Tetra­aqua­bis­(N,N-dimethyl­formamide-κO)zinc(II) bis­[(2-{3-[2-(carboxyl­ato­meth­oxy-κ(2) O,O′)phen­yl]pyrazol-1-yl-κN (2)}acetato-κO)chloridozincate(II)]
title_full_unstemmed Tetra­aqua­bis­(N,N-dimethyl­formamide-κO)zinc(II) bis­[(2-{3-[2-(carboxyl­ato­meth­oxy-κ(2) O,O′)phen­yl]pyrazol-1-yl-κN (2)}acetato-κO)chloridozincate(II)]
title_short Tetra­aqua­bis­(N,N-dimethyl­formamide-κO)zinc(II) bis­[(2-{3-[2-(carboxyl­ato­meth­oxy-κ(2) O,O′)phen­yl]pyrazol-1-yl-κN (2)}acetato-κO)chloridozincate(II)]
title_sort tetra­aqua­bis­(n,n-dimethyl­formamide-κo)zinc(ii) bis­[(2-{3-[2-(carboxyl­ato­meth­oxy-κ(2) o,o′)phen­yl]pyrazol-1-yl-κn (2)}acetato-κo)chloridozincate(ii)]
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379139/
https://www.ncbi.nlm.nih.gov/pubmed/22719360
http://dx.doi.org/10.1107/S1600536812023045
work_keys_str_mv AT yangjie tetraaquabisnndimethylformamidekozinciibis232carboxylatomethoxyk2oophenylpyrazol1ylkn2acetatokochloridozincateii
AT shenlei tetraaquabisnndimethylformamidekozinciibis232carboxylatomethoxyk2oophenylpyrazol1ylkn2acetatokochloridozincateii
AT jicheng tetraaquabisnndimethylformamidekozinciibis232carboxylatomethoxyk2oophenylpyrazol1ylkn2acetatokochloridozincateii
AT shenxiaofeng tetraaquabisnndimethylformamidekozinciibis232carboxylatomethoxyk2oophenylpyrazol1ylkn2acetatokochloridozincateii
AT yanggaoweng tetraaquabisnndimethylformamidekozinciibis232carboxylatomethoxyk2oophenylpyrazol1ylkn2acetatokochloridozincateii